Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial comparing azithromycin versus probiotics for acne vulgaris has completed.
-
FDA approval · 2022-10-31FDA Approved: AZELAIC ACID — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for azelaic acid from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2022-10-06FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for CLARAVIS (isotretinoin), a supplemental approval for the product.
-
FDA approval · 2022-10-06FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for AMNESTEEM (isotretinoin) submitted by Mylan Pharmaceuticals, updating labeling for its acne trea…
-
FDA approval · 2022-10-06FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) to Teva Pharmaceuticals USA, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-10-06FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zenatane (isotretinoin) submitted by BluePoint Laboratories.
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for isotretinoin filed by Amneal Pharmaceuticals NY LLC, resulting in updated labeling for isotretin…
-
FDA approval · 2022-10-06FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approves a supplemental application for ABSORICA LD (isotretinoin) filed by Sun Pharmaceutical Industries, resulting in updated labe…
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA has approved a supplemental application for isotretinoin from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for isotretinoin submitted by Actavis Pharma, Inc. The approval pertains to changes in labeling …
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for isotretinoin from Mayne Pharma.
-
FDA approval · 2022-10-06FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for isotretinoin submitted by Upsher-Smith Laboratories, LLC, indicating an approved change related …
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study in subjects with acne vulgaris; study completed with results posted.
-
FDA approval · 2022-09-13FDA Approved: TAZAROTENE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' generic tazarotene through an Original Application (ANDA 215433). The product is intended for the trea…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Topical Metformin Emulgel VS Salicylic Acid Peeling in Treatment of Acne Vulgaris [Phase 4]
A Phase 4 clinical trial comparing topical metformin emulgel with salicylic acid peeling for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Measure the Serum Level of Homocysteine in Acne Patients Before and After Oral Isotretinoin. [Phase 4]
Phase 4 study measuring serum homocysteine in acne patients before and after oral isotretinoin completed.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Effect of Oral Isotretinoin on The Level of SerumYKL40 in Acne Vulgaris Patients [Phase 4]
Phase 4 clinical trial investigating the effect of oral isotretinoin on serum YKL-40 levels in acne vulgaris patients.
-
FDA approval · 2022-08-25FDA Approved: ADAPALENE — Supplemental Application (Mayne Pharma Commercial LLC.)
FDA approves a supplemental application for adapalene from Mayne Pharma Commercial LLC., likely related to labeling updates for acne treatme…
-
FDA approval · 2022-08-24FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved a supplemental application for isotretinoin submitted by Mayne Pharma.
-
FDA approval · 2022-08-24FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for isotretinoin from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2022-08-24FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for isotretinoin submitted by Upsher-Smith Laboratories, LLC. This document indicates a suppleme…
-
FDA label_change · 2022-08-24FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for isotretinoin from Amneal Pharmaceuticals NY LLC, resulting in changes to the drug's labeling.
-
FDA approval · 2022-08-23FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc., authorizing changes to the prod…
-
FDA approval · 2022-08-23FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc., indicating regulatory clearance…